Recent Posts
- [2024/11/22] Gene and Cell Therapy- weekly digest from PackGene
- Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B
- Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer
- Vyriad announces strategic collaboration with Novartis to develop in vivo CAR-T cell therapies
- Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B
AAV One-stop Solution
Tags
AAV2
AAV5
AAV based gene therapy
AAV Capsid
ALS
Alzheimer’s Disease
brain vasculature
cancer
CAR-T
Cell Therapy
COVID-19
COVID vaccine
CRISPR
CRISPR/Cas
Drug Development
dystrophin
eye disease
FDA
gene editing
gene therapy
genetic engineering
genome editing
GMP plasmid
hearing
heart disease
hemophilia
Hemophilia B
hepatitis research
HIV
immunotherapy
liver cancer
mRNA
Neurodegenerative Diseases
Orphan Drug
Parkinson
rare disease
Retinoschisis
RNA
RNAi therapeutics
RNA vaccines
SARS-CoV-2
Sickle Cell Disease
SMA Treatment
thyroid
zolgensma